Skip to main content

NCT00270283 - A Double-Blind, Placebo-Controlled Study With Open-Label Follow-up to Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy

A Double-Blind, Placebo-Controlled Study With Open-Label Follow-up to Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy

Data Request Dashboard

Operations

No data requests found. Click here to generate a new one.


Data Specification

Not Yet Available


Annotated CRF

Not Yet Available

Product Info

Generic Name
Epoetin alfa
Product Name
PROCRIT®
Therapeutic Area
Blood and Lymph Conditions
Enrollment
102
Product Class
Colony-stimulating factors
Sponsor Protocol Number
CR006076 (I88-009)
Data Holder
Johnson & Johnson
Condition Studied
AIDS, Anemia

Supporting Documentation

Analysis Datasets
Collected Datasets
Study Phase 
2

APPROVED DATA REQUESTS ASSOCIATED WITH THIS TRIAL

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.